Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Skin Neoplasms × Arsenic Trioxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Promyelocytic, Acute 18 Leukemia 18 Leukemia, Myeloid, Acute 13 Multiple Myeloma 11 Neoplasms, Plasma Cell 7 Myelodysplastic Syndromes 7 Leukemia, Myelomonocytic, Chronic 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Monocytic, Acute 5 Neoplasms 4 Lymphoma 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Erythroblastic, Acute 4 Central Nervous System Neoplasms 4 Blast Crisis 4 Anemia, Refractory, with Excess of Blasts 4 Recurrence 3 Neoplasm Metastasis 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Carcinoma, Hepatocellular 3 Burkitt Lymphoma 3

Interventions

Nivolumab 12 Ipilimumab 10 pembrolizumab 8 Surveys and Questionnaires 6 Biopsy 6 cemiplimab 5 Radiotherapy 5 Blood Specimen Collection 5 aldesleukin 4 Photochemotherapy 4 Interleukin-2 4 Fluorouracil 4 Educational Status 4 avelumab 3 Vemurafenib 3 Temozolomide 3 Surgical Procedures, Operative 3 Sirolimus 3 Radiation 3 Petrolatum 3 Cyclophosphamide 3 Cetuximab 3 Aminolevulinic Acid 3 trametinib 2 sonidegib 2 fludarabine phosphate 2 fludarabine 2 dabrafenib 2 atezolizumab 2 Vinblastine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01791894 2018-06-08

ATO

Stanford University

Phase 1/2 Completed

5 enrolled 9 charts

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡